InspireMD (NASDAQ: NSPR) reported Q1 EPS of ($0.22), $0.09 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $1.53 million versus the consensus estimate of $1.79 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.